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1. Introduction  
Ten years ago, the US Institute of Medicine (IOM) called for a massive redesign of the 
healthcare delivery system.(Committee on Quality of Health Care in America, 2001) Today 
it is clear that one of the goals, the nationwide use of an electronic medical record (EMR) by 
2010, has failed to be reached as the process of adoption has been slow. Some may consider 
an EMR as a final destination, although in fact it is only the start point of a revolution in 
healthcare: the implementation of clinical decision support systems (CDSS) that ‘make  
it easy to do it right’.(James, 2001) These systems are able to address the large, potential 
additional value of the implementation of an EMR. When an EMR is available, this  
is already a step in the right direction, to have an easy and structured access to all patient 
data available for all healthcare professionals that need them. However, this is still a huge 
amount of data, but one should also have the ability to integrate all these data and use these 
data in making the right choices in therapy. Practice has shown that despite the availability 
of an EMR, still many medication errors are made. Therefore, CDSS are designed to  
aid clinical decision-making by matching patient characteristics to a computerized 
knowledge or rule base to generate patient-specific recommendations.(Kawamoto et al., 
2005) In the trendsetting IOM reports ‘To Err is Human’ (2000) and ‘Crossing the quality 
chasm’ (2001), a CDSS was endorsed as one of the most powerful tools available for 
improving patient safety and healthcare quality.(Kohn et al., 2000;Committee on Quality of 
Health Care in America, 2001) 
It is difficult to accept that despite multiple opportunities and promising results, these 
systems instead of being common practice, still remain ‘next-generation’.(James, 2001)  
During the last five years, research gave more insight in the success factors that could 
accelerate the idle process of CDSS adoption. (Kawamoto et al., 2005; Garg et al., 2005;Nies 
et al., 2006) The conclusions however are not univocal because the reviews included a wide 
variety of systems ranging from computerised to non-computerised CDSS as well as from 
basic to advanced systems. Basic decision support includes checking on drug-drug 
interactions, duplicate therapy, drug-allergies and generalized drug dosing. Advanced 
CDSS, used in addition to basic CDSS, includes for example checking on contra-indications 
(disease and drugs), individualized dosing support during renal impairment or guidance 
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for medication-related laboratory testing.(Kuperman et al., 2007) Basic decision support is 
nowadays commonly available. In the Netherlands, this provision is used nationwide since 
1980, integrated in a drug database (G-standaard, Royal Dutch Association for the 
Advancement of Pharmacy). Despite this support that is available for every physician and 
pharmacy, medication errors occur frequently which emphasizes the urge for advanced 
solutions.(Leendertse et al., 2008)  
In our 600-bed university-affiliated hospital, we have implemented an advanced CDSS in 
practice on a few departments already and are on the eve of hospital-wide expansion. A 
critical examination of the literature made clear which prerequisites are needed for optimal 
implementation of advanced CDSS. To accelerate the process of CDSS adoption, we present 
an overview of success factors and barriers for implementation of advanced CDSS in 
hospital practice. Subsequently, we present our own experienced success factors and 
barriers after implementing an advanced decision support system in 2008 in daily hospital 
practice and compare these results with literature findings.  
2. Background 
Medication errors occur distressingly frequent due to deficiencies in the overall system of 
healthcare delivery despite use of current medication safety systems.(Kohn et al., 
2000;Committee on Quality of Health Care in America, 2001;Schiff et al., 2003) Many 
reports call attention to the gaps between optimal and actual practice. (Kohn et al., 
2000;Committee on Quality of Health Care in America, 2001;Aspden et al., 2006)  
The report ‘To Err is human’ indicated that 44.000 to 98.000 patients die in hospitals each 
year due to medical errors.(Kohn et al., 2000) The recent IOM report ‘Preventing Medication 
Errors’(Aspden et al., 2006) showed that in the USA medications harm at least 1.5 million 
people per year of which at least 400,000 preventable adverse drug events (ADE’s) in 
hospitals.  
The number of patients, dying from medical errors is probably a low estimate and the 
situation in Europe is not expected to be different. The Dutch statistics are, for example, not 
encouraging either. From the patients that died in Dutch hospitals in 2007, 10.7% 
experienced preventable medical complications; resulting in the death of 1735 patients 
(4.1%). Even more discouraging is the fact that the number of unnecessary deaths tends to 
increase. For the Netherlands these were 1745 deaths in 2004 and 1960 in 2008; an increase 
of 11.5%, despite advances in knowledge and IT-systems (Langelaan, 2010) The HARM-
report (2006, NL) showed 19.000 preventable drug related admissions a year in Dutch 
hospitals; 5.6 % of all acute admissions, associated with a total cost of 86 million 
euros.(Leendertse et al., 2008) 
Medication errors occur due to the rapidly increasing complexity of evidence based 
medicine and error sensitivity of healthcare.(James, 2002) Physicians need to take many 
drug- and patient specific characteristics into account and literature shows that this is often 
omitted or not recognized in time.(Levy et al., 1999;Schiff et al., 2003;Denekamp, 2007) 
Beyond reminders, CDSS can integrate clinical data to support professionals managing an 
increasingly complex practice environment.(James, 2001) Integration of these specific 
parameters is necessary to guide patients through the complete clinical pathway from 
anamnesis to evaluation and fine-tuning of the therapy.  
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Reviews of Kawamoto and Garg have shown that a CDSS is effective in decreasing 
medication errors and improving efficiency and quality of care.(Kawamoto et al., 2005;Garg 
et al., 2005) These reviews found that 64% respectively 68% of the decision support systems 
significantly improve clinical practice.(Kawamoto et al., 2005;Garg et al., 2005)  
In literature, basic and advanced decision support are both called CDSS and exact 
descriptions of the systems used are scarce, which makes these systems difficult to compare. 
This review will only include advanced CDSS, defined as a multi-purpose rule based expert 
system which contains complex electronic guidelines that can integrate data from different 
domains.(Sucher et al., 2008) Goals of implementing advanced CDSS are to decrease errors 
and improve patient safety, improve quality through adoption of best practices, increase 
cost-effectiveness and optimize the management of chronic diseases.(Greenes, 2007) In our 
hospital, research is performed with clinical decision support since 1998, in which we found 
that these goals can be achieved though structured development, validation and 
implementation. The objective of this chapter is to extend a practical overview of success 
factors and barriers of advanced CDSS found in literature and practice, before widespread 
hospital implementation, concentrating on these central aspects.  
3. Success factors 
Right message Accurate content 
 Reliable messages 
 Easy and actionable messages 
 Inclusion of references in the message 
Right time Save time 
 Integration in workflow 
 High system’s speed 
Right place Deliver message at the point of care 
 Active alerting mechanism 
Right system Electronic availability of data in the EMR 
 Integration with other systems 
 Maintenance of the system and content 
Table 1. Overview of success factors for implementation of advanced CDSS (see text for 
references) 
3.1 The right message 
3.1.1 Accurate content 
To facilitate the adoption of evidence based medicine in practice, paper guidelines have to 
be translated into a computer-interpretable format, called clinical rules. This is a challenging 
task, because evidence based recommendations are often non-specific, multi-interpretable 
and either too complex to recall or too general to apply specifically.(Trivedi et al., 
2002;Denekamp, 2007;Kuperman et al., 2007;Sucher et al., 2008) For example, according to 
guidelines, leukocyte counts should be measured frequent during lithium therapy, but the 
exact frequency, cut-off values and relevance is lacking.(Wessels-Basten et al., 2007) This 
problem can be solved by involving a multidisciplinary expert team to review and optimize 
the clinical rules.(Dexter et al., 2001;Trivedi et al., 2002;Osheroff et al., 2005;Leslie and 
Denvir, 2007;Wessels-Basten et al., 2007) One should compose the expert team carefully, 
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being a reflection of end users and recognised experts in the particular field, as this 
determines the strength of the clinical rule developed. In fact, this is generally alike to the 
development of a new guideline. Benefits of this approach are that the specific subject gains 
renewed attention from the experts which may already increase compliance to these 
guidelines and user commitment is gained as the experts will be end-users of the system 
and motivate other users once implemented in practice.(de Clercq and Hasman, 
2004;Osheroff et al., 2005;Wessels-Basten et al., 2007)  
3.1.2 Reliable messages 
Current medication safety systems generate masses of irrelevant alerts leading to alert 
fatigue as a result of the often low specificity and clinical relevance.(van der Sijs et al., 2006) 
This is especially the case with basic, drug-oriented decision support, as we know in the 
Netherlands for about 30 years. Many alerts are generated, and the research of van der  
Sijs showed that more than 90% of alerts are overridden, without the physician even looking 
at the alert. The underlying conditions are: low alert specificity, information content unclear, 
low sensitivity, handling was insufficient and unsafe and the workflow was unnecessary 
disrupted. Also, physicians were not trained on the alerts and trusted the pharmacy  
in checking their medication orders. In summary, there are many failures of the systems 
used today, that can be solved with these new advanced decision support systems. Even, 
these current systems can be dangerous, which pleads for a rapid response. These basic 
systems increases the risk of overriding a potentially harmful alert.(Bates et al., 2003;van  
der Sijs et al., 2006;Denekamp, 2007) Even pharmacists have been found to override a third 
of life-threatening drug-drug interactions.(Bates et al., 2003) Therefore, it is vitally important 
to validate the clinical rules extensively before bringing these into practice to ensure reliable 
recommendations.(Dexter et al., 2001;Wetter, 2002;Wessels-Basten et al., 2007;Sucher et  
al., 2008;Varonen et al., 2008) The above mentioned obstacles need to be taken into account 
when designing en implementing these newer systems. Also, validation of the alerts  
is fundamental for success. Scheepers et al (2009) has described a strategy that can be used 
in various settings to create clinical rules of a high reliability. By measuring the positive  
and negative predictive value during the development process and afterwards, one can 
easily monitor if the quality of the clinical rules is high enough before implementation in 
practice. Since few studies have focused on validation of clinical rules, more research is 
needed. There is a need for other successful strategies to be described, to help others with 
these fundamental questions. Also, research may answer the question which minimal 
notification threshold is needed for effective alerting before bringing the alert into 
practice.(Osheroff et al., 2005)  
3.1.3 Easy and actionable messages 
A CDSS is effective when it minimizes the effort required by physicians to receive and act 
on system recommendations.(Kawamoto et al., 2005;Varonen et al., 2008) This can be 
accomplished by giving clear advice and a straightforward way to perform the action 
indicated. (Bates et al., 2003;Osheroff et al., 2005;Varonen et al., 2008;Mollon et al., 2009) 
Besides that, applications must anticipate physicians needs for gathering and translating 
data into actionable recommendations.(Bates et al., 2003;Kawamoto et al., 2005;Mollon et 
al., 2009) For example, a clinical rule is developed to check if a patient needs a gastro-
protective drug when using a NSAID or dosage adjustment because of renal insufficiency. 
www.intechopen.com
 
Success Factors and Barriers for Implementation of Advanced Clinical Decision Support Systems 
 
35 
(Field et al., 2008) If necessary, an automatic medication order pops-up and only one click 
on the ‘authorize’ button is needed to prevent the patient from having adverse drug 
events. This is all in line with the words of James (2001) to ‘Make it easy to do it right’ and 
emphasises the need of an expert/end users team that is well involved in the 
development process.  
3.1.4 Inclusion of references in the message 
A valuable addition to the message is to present the source of the information and the 
explanation of the rationale for the guideline.(Maviglia et al., 2003;Kawamoto et al., 2005; 
Goud et al., 2008;Mollon et al., 2009) Many guidelines exist and these are continuously 
renewed, which makes it difficult to keep up with all recommendations. Although it 
appears that not all users use this option(Bates et al., 2003), it is a valuable addition that 
literature citations and web-based evidence are available when desired. (Bates et al.,  
2003) 
3.2 The right time 
3.2.1 Save time 
Physicians encounter a barrier to invest time in another computer system. All health 
professionals face time pressure and increasing data overload. The number of therapies is so 
large that physicians cannot effectively keep track of them all.(Bates et al., 2003) A CDSS 
can save time by making associations between different data domains, which physicians 
might miss because of the large amount of data. Time saving can be achieved by making it 
easy to do it right and is therefore a highly valued success factor.(Wetter, 2002; Mollon et 
al., 2009) It is important to find the right balance between over- and under reporting in 
accordance with the wishes of the end-users of the system and to convince users that the 
added value of the system compensates for the time required to learn and use the 
system.(Goud et al., 2008)  
3.2.2 Integration in clinical workflow 
The most important success factor of CDSS is that the system is integrated in the clinical 
workflow.(Kawamoto et al., 2005;Osheroff et al., 2005;Mollon et al., 2009) A CDSS will 
otherwise have no beneficial effect and will not be used. Messages should be presented at 
the moment of decision making, though with as less disturbance for the physician as 
possible. Therefore different alert mechanisms (pop-up, automatic lab order, prescription 
order, email, etc) should be developed, suitable for different alerting priorities.(Osheroff et 
al., 2005) In this particular field, the research is very limited and needs to be expanded soon. 
Understanding the clinical workflow and user’s wishes thoroughly strongly increases the 
probability for success.(Bates et al., 2003) 
3.2.3 High system’s speed 
As with every computer system, speed is a very important parameter for user’s acceptance. 
(Mollon et al., 2009) As explained above, recommendations should appear exactly at the 
right time of decision making. When the speed of an application is slow, user satisfaction 
declines markedly. Bates et al found that this parameter is valued most by users and 
therefore it should be a priority factor of the CDSS.(Bates et al., 2003) 
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3.3 The right place 
3.3.1 Point of care 
An important quality of advanced CDSS is the ability to deliver recommendations at the 
point of care.(Mollon et al., 2009) The question is who should receive the message. The point 
of care may vary, as patients therapy is guided by various health professionals in the 
process. The multidisciplinary expert team can identify the receiver of the recommendations 
(e.g. physician, pharmacist, nurse etc).(Wessels-Basten et al., 2007) 
3.3.2 Active alert mechanism 
The performance of systems in which users are automatically prompted to use the system is 
significantly more effective, compared with studies in which users were required to actively 
initiate the system.(Dexter et al., 2001; Kawamoto et al., 2005; Garg et al., 2005; van Wyk et 
al., 2008) Also a larger positive impact is seen when a recommendation is prompting for an 
action and not ignorable.(Dexter et al., 2001; Bates et al., 2003) Dexter found that relatively 
small changes in the presentation of alerts made the difference between a significantly 
increase in preventive measurement rates and no effect at all.(Dexter et al., 2001) So it is 
important to select the alert mechanism carefully, as the type of alert will greatly affect the 
impact of the clinical rule.  
3.4 The right system 
3.4.1 Electronic availability of data 
A CDSS acts on electronically available patient data in the EMR (clinical data, pharmacy, 
laboratory, diagnoses, complications, microbiology etc).(Soman et al., 2008) Progress of 
implementation and adoption of EMR is slow, which inhibits adoption of CDSS. The most 
specific and advanced clinical rules can be developed if a CDSS is able to gather all 
mentioned data from the EMR, but at least a pharmacy-laboratory link is needed. (Schiff et 
al., 2003; Maviglia et al., 2003; Jha et al., 2008) The ability to integrate outpatient data in the 
CDSS can give additional improvements for more specific clinical rules.(Goud et al., 2008)   
3.4.2 Integration with other systems 
Integrated systems (e.g. in CPOE) are significantly more likely to succeed than stand alone 
systems.(Kawamoto et al., 2005;Garg et al., 2005;Mollon et al., 2009) This provides relevant 
information to physicians at key times in decision making, enabling to prompt alerts during 
drug prescription or chart review.(Denekamp, 2007;Varonen et al., 2008)  
3.4.3 Maintenance of system and content 
Once a CDSS is implemented it is essential for long term success that the system and content 
remains up-to-date.(Trivedi et al., 2009) Technical maintenance is important to guarantee a 
flawless link between the CDSS and the EMR. Maintenance concerning content is needed to 
ensure that the clinical rules remain applicable regarding the latest evidence-based 
guidelines.(Osheroff et al., 2005) Sometimes corrections are required after implementation 
when it turns out that the impact or physician’s satisfaction is not as expected.(Trivedi et al., 
2002;Bates et al., 2003) Therefore Bates et al(Bates et al., 2003) assigned each area of decision 
support to an individual. For example, a cardiologist has to evaluate the clinical rules 
regarding his specialism periodically. Regarding the novelty of complex CDSS, maintenance 
of the system and content is hardly studied yet.   
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4. Barriers 
Certain barriers found in literature may hamper implementation of advanced CDSS. Besides 
the lack of the described success factors, an often mentioned barrier to implementation is 
low computer skills among physicians.(Garg et al., 2005;Leslie and Denvir, 2007;Trivedi et 
al., 2009) This must be carefully taken into account within the design of the alerts. New-
generation physicians, like medical students and junior doctors, may bring a higher level of 
computer literacy to clinical practice and stimulate implementation of a CDSS in practice. 
(Leslie and Denvir, 2007)    
Another barrier, brought forward by Bates(Bates et al., 2003), is the loss of physician’s 
autonomy with the use of CDSS. However, CDSS are able to present the best evidence-based 
practice automatically, without requiring extra thought or work. This allows the health 
professionals to focus on those areas of special need and adjust care to each individual 
patient.(James, 2002) This not only increases patient safety, but also physician’s safety by 
reducing the risk on malpractice claims. Even, the system may improve clinical skills 
through a learn effect of the corrective messages.(Varonen et al., 2008)  
5. Own experienced success factors and barriers 
In our years of research we evolved a development and validation strategy for clinical rules. 
This three-step strategy (retrospective technical, retrospective therapeutic and prospective 
validation step), following a Plan-do-check-act-cycle in combination with an expert team, 
has led to high success rates.(Wessels-Basten et al., 2007;Helmons et al., 2009)  We found that 
a well considered strategy, that creates rules with a high positive predictive value (PPV) is 
essential for accurate content and reliable messages. Application of this strategy has led to 
clinical rules with a reliability (PPV) of at least 94%, which indicates that more than 94% of 
the alerts are technically correct and clinically relevant as indicated by the expert team and 
end-users.(Wessels-Basten et al., 2007)  
This strategy mentioned is described in detail in another publication (Scheepers, 2009) and 
tries to solve important barriers described earlier, especially the ones regarding content and 
reliability. In our hospital we use the advanced CDSS Gaston, a commercially available 
system described in many publications. (de Clercq, 2004). Gaston is a software system – you 
could also call it an intelligent agent – that consists of two parts. The first part – the 
guideline-editor (Fig. 1) – allows the user to build the guidelines as flowcharts in a user-
friendly environment. The steps in the flowchart contain the selection definitions based on 
the parameters that are available in the EHR. The second part, the decision support module 
(DCS) is the guideline execution engine. This engine translates the guideline from the 
guideline-editor into a routine that can be executed.  
As the expert team is the key quality of the strategy developed in our previous research, we 
experienced some specific factors that need to be taken into account. These aspects may help 
others to compose the right team in order to optimised outcomes: 
- Define the objective clearly. The context of the clinical rule and how it will be applied in 
practice should be clear for all participants.  
- Start by making a clear structure in which the clinical rule is developed. Some content 
covers only one drug, some covers a certain drug class, while others concern a complete 
(contra-)indication. One should try to classify the content correctly.  
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- Develop the clinical rule in a way that is clear for all participants before start and in a 
structured way with a pre-defined strategy.  
- Compose the team of experts with experts from different departments and specialisms. 
Also, compose the team with people that can be trusted to have an active role in the 
discussion and reflect the opinion of others well. 
- Communicate to the experts what effort is expected form them and how much time it 
will cost them. How will they be rewarded for their input.  
- Communicate clearly how feedback will be given, in meetings or digital 
communication.  
- Determine how decisions are made when not all experts agree. Which experts are 
identified as having the last word or should there be a majority with the same opinion.  
- When opinions differ, stay objective as being the chairman of the session. Try to make a 
clear overview of all pro- and contra arguments and try to literature to create an 
agreement.  
 
 
Fig. 1. Screenshot of the Gaston Guideline Editor, with an example of a clinical rule, build as 
a flowchart to cover the complete therapy of lithium. 
Integration of all computer systems in one environment is also found to be important to ease 
implementation. In our hospital, CPOE is integrated in the EMR. Only one link is needed 
between CDSS and EMR/CPOE which facilitates technical implementation, maintenance 
and costs.(de Clercq and Hasman, 2004) An example: we found that every time the EMR 
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was upgraded to a new version, also adaptations in de CDSS were needed. Besides these 
two factors, we experienced that the success factors as described above are important for an 
effective foundation before widespread hospital implementation. 
5.1 Barriers experienced in practice 
When the dependence on a CDSS is growing for the checking of guidelines in a more 
consistent and reliable way, it is necessary that the well-functioning of the CDSS is 
guaranteed in the hospital. During our research we experienced a lot of barriers. For the 
guarantee of well-functioning, the following ‘commandments’ need to be addressed: 
1. Stability and performance of the CDSS: When the CDSS is increasingly used, it may 
impact the performance of the system itself as well as other systems. It is important that 
the position of the CDSS is well known amongst all and that these performance 
problems are known, controlled and monitored continuously by the ICT-department.  
2. Maintenance of the CDSS: Maintenance can be divided in functional and technical 
maintenance, with different responsibilities. It should be indicated clearly who is 
responsible for the content of the system and all the parameters used in these clinical 
rules (functional). This is usually a task for the medical professional, who builds, tests 
and releases these clinical guidelines. Between function and technical maintenance is 
the maintenance of the data and parameters used (data dictionary). When a 
parameter, location or database structure are changed for the information systems 
that feed the CDSS with data (e.g. the EHR or laboratory information system), the 
data dictionary of the CDSS should be changed accordingly. The use of so-called 
‘free-text’ in the data feeding information systems should be minimized for as much 
as possible. Typo-errors or different use of text for the same concept makes it 
impossible to guarantee the correct functioning of the CDSS. Technical maintenance 
includes the maintenance of the CDSS application, installing updates and new 
releases of the CDSS (and EHR) and testing the technical correct functioning of the 
CDSS. Because a CDSS uses data from other information systems like the EHR, it is 
important that technical testing of the CDSS is also performed after installing updates 
or new releases of other information systems like the EHR. This is usually done by 
the ICT-department. In addition, advanced reporting-systems should be able for 
signalling and solving errors of the CDSS. When one is not aware of an error or 
malfunctioning of the CDSS, the patient safety could be at risk without anybody 
noticing it. The responsibility of the functional and technical maintenance of the 
CDSS should be clearly defined and time and budget should be available for medical 
professionals and the hospital IT –department. 
3. Skills and knowledge of personnel: When there are errors concerning the CDSS, one 
should be able to estimate the possible risks on patient safety and immediately act upon it. 
This requires effort from all personnel, medical as well as IT personnel. Documentation on 
the guidelines, possible errors and their risks and an emergency procedure, in case of 
malfunctioning of the CDSS is an important aspect of the safe use of a CDSS. 
4. A generalised format: Agreements should be made between the hospital departments 
about the layout, priority and content of warnings of the CDSS, the way they should 
respond to them and the content of guidelines. The presence of a wide variety of 
warnings could cause that medical professionals lose interest for them. In that case the 
warnings of the CDSS are not used and their additional value declines.  
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5. Continuity and support of the CDSS vendor: This support is essential for continued 
technical quality of the system and the validated manner of application in practice. In 
every setting local adaptations are needed to fulfil the demands of the CDSS customer.  
6. Comprehensive testing protocols: These should be available for the testing of 
guidelines before implementation and for the testing of guidelines after new releases 
and updates. Also testing protocols should be available for the technical testing of the 
CDSS. When the number of guidelines increases in a hospital, it will cost an 
increasing amount of time to test all the guidelines after a new release or update. One 
should develop testing strategies, which allow adequate testing within a limited 
amount of time. 
This list is not a complete list and not a completely new list: Most of the issues are also 
applicable for other information systems like the EHR itself. It is important that the issues on 
this list are addressed because downtime and malfunctioning of the EHR or the CDSS have 
severe implications for the hospital and its patients. One should be aware that 
malfunctioning of the CDSS is not immediately visible for the medical professional because 
it generally results in the absence of warnings. Warnings are, however, not always present, 
only in case of treatment differing from guidelines. The absence of warnings will therefore 
not automatically alarm a medical professional. Continuously monitoring of the CDSS by 
the IT department is therefore important, to prevent unreported malfunctioning CDSS, 
which is a potential risk for patient safety. 
6. Discussion 
The primary finding in this chapter is that many factors determine the successful 
implementation of advanced decision support. Although several publications have 
addressed the need of detailed description of system design and implementation features, 
these are continuously poorly reported.(Kawamoto et al., 2005;Garg et al., 2005;Mollon et al., 
2009) Also the definition of a CDSS is used confusingly, as they include a wide variety of 
computerized and non-computerized systems that apply basic and advanced decision 
support. This complicates to conclude which factors really contribute to success of advanced 
decision support and seriously hampers widespread implementation of these systems that 
are so urgently needed.  
The implementation of effective clinical decision support is a challenging task and in this 
complex process there are no easy solutions to guarantee success or to avoid failure. When 
starting with a CDSS, first certain prerequisites must be met. First, nationwide adoption of 
an EMR must be accelerated, as this is a prerequisite for CDSS adoption. Secondly, it is 
important to gather the right data and create a clinical rule with high reliability with 
technically correct and clinically relevant messages. Essential is that an effective system 
must minimize the effort required by clinicians to receive and act on systems 
recommendations.(Kawamoto et al., 2005) Last but not least, the commitment and 
participation of physicians as most frequent end-users is crucial for success.(Bates et al., 
2003) It is important to identify stakeholders that support the implementation and a 
multidisciplinary team to achieve realisation, distribution and continuation.(Osheroff et al., 
2005) When these people address the value and possibilities of these systems, time and 
money can be made available. It is very time consuming to add knowledge to a CDSS, 
continuously test and validate the clinical rules and recommendations. Consequently, high 
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costs are associated with the development of clinical rules and the cost-effectiveness of 
CDSS has rarely been studied yet.(Field et al., 2008)  
Nevertheless, a CDSS is a powerful tool that can even fulfil ‘latent needs’. These needs, that 
are present but not yet realized, can be fulfilled by detecting errors that need prevention but 
are too time-consuming with current possibilities. An example is the clinical rule for renal 
function Helmons et al developed.(Helmons et al., 2009) This clinical rule checks when a 
patient has a decreased renal function and dose adjustments of the medication are 
necessary. Compared to chart review, this clinical rule decreases time needed for checking 
and intervention by 80%. This example illustrates that today many gaps exist between 
optimal and actual practice. Although a pharmacist should check all patients on the 
combination of drug dosing and decreased renal function, in the current situation it is 
impossible as time is limited. Our research shows that with every developed clinical rule, 
remarkable differences between guidelines and practice were found, even though guidelines 
are well known.(Wessels-Basten et al., 2007;Helmons et al., 2009) Prospective research must 
demonstrate the effect of these clinical rules in practice.  
7. Conclusion and further recommendations 
This chapter demonstrates a practical overview of success factors which are crucial for 
successful implementation of advanced CDSS to facilitate widespread implementation in 
hospital practice. These success factors are focused on presenting the right message, at the 
right time, in the right place with the right system. More adequate descriptions of system 
design features and implementation are needed to translate these factors to effects on 
patient outcomes.  
CDSS are expected to unchain a revolution in healthcare and fill the existing information 
gap by bringing relevant data and knowledge to the point of care.(Bates et al., 2003) Despite 
the consciousness that change is indispensable and the years of research and effort 
worldwide, this has only led to slow adoption of EMR and CDSS. We believe it is now the 
time to bring these identified success factors in practice to accelerate the adoption of these 
systems and reap the benefits of this promising next-generation in medication safety.  
More research is needed in most areas concerning CDSS (Kuperman et al., 2007;van Wyk et 
al., 2008) The focus of this research should be which alerting mechanism (list, pop-ups, e-
mail, SMS, dedicated quality persons) results in the best adherence of physicians to 
previously agreed standards of care and how do these methods effect patient outcomes? 
Eventually this will give an answer to the question: how to optimally implement a CDSS in 
clinical practice in order to reduce errors and omissions so frequently noted.  
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